Competitive Landscape of COVID-19 Therapies

Evaluation of COVID-19 Developmental Pipeline Therapies
Objective :

COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.

Problem Statement:

A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.

Our Methodology:
  • Therapeutic R&D Developmental Pipeline Assessment
  • Assessment of the Drugs
  • Key Pharmaceuticals Portfolio Assessment
  • Strategic Planning Assistance
  • Detailed profiling of Active Products in the Pipeline
  • Landscape analysis of various Mechanisms of Action and Routes of Administration
  • Matrix Analysis positioned the top 10 Companies researched.
  • The client can appraise all the top companies that can serve as a potential competition

Related Insights

Competitive Intelligence
Competitive Intelligence

A global pharmaceutical company desired a web-based, robust and simplified, and user-friendly interactive dashboard that encompasses launch timelines, study start date and primary completion... [...]

View Case
Regulatory Analysis
Regulatory Analysis

A large client based in Europe, involved in Dermatology arena with a market-ready product, aimed to assess the Indian Regulatory Scenario to successfully file the product in CDSCO. [...]

View Case
Product Assessment
Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.